Home
>
National Drug Code (NDC)
>
CAPTOPRIL
CAPTOPRIL - 50436-6104-1 - (CAPTOPRIL)
Drug Information of CAPTOPRIL
| Product NDC: | 50436-6104 |
| Proprietary Name: | CAPTOPRIL |
| Non Proprietary Name: | CAPTOPRIL |
| Active Ingredient(s): | 12.5 mg/1 & nbsp; CAPTOPRIL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CAPTOPRIL
| Product NDC: | 50436-6104 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074532 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970328 |
Package Information of CAPTOPRIL
| Package NDC: | 50436-6104-1 |
| Package Description: | 30 TABLET in 1 BOTTLE (50436-6104-1) |
NDC Information of CAPTOPRIL
| NDC Code | 50436-6104-1 |
| Proprietary Name | CAPTOPRIL |
| Package Description | 30 TABLET in 1 BOTTLE (50436-6104-1) |
| Product NDC | 50436-6104 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CAPTOPRIL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970328 |
| Marketing Category Name | ANDA |
| Labeler Name | Unit Dose Services |
| Substance Name | CAPTOPRIL |
| Strength Number | 12.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
